Clinical Trials in Detroit

Showing 10701-10720 of 16,931 trials

Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone

NCT03762902

This study is conducted at the Henry Ford Health System with Lifegraph's behavioral monitoring technology, to examine the relation between migraine attacks and behavioral and environmental changes as detected from the smartphone sensors. The investigators hypothesize that Lifegraph's technology can predict the occurrence of migraine attacks with high precision.

Migraine DisordersHeadache DisordersHeadache Disorders, Primary+3 more

Lifegraph Ltd.10 participantsStarted Apr 2019

Detroit, Michigan, United States • West Bloomfield, Michigan, United States

COMPLETEDPhase 1/2< 1 mile

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

NCT02518113

The main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with dexamethasone in participants with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma (T-ALL/T-LBL).

T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma

Eli Lilly and Company36 participantsStarted Oct 2015

Duarte, California, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +19 more locations

Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Find Trials by Condition in Detroit

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

AZMATICS: AZithroMycin/Asthma Trial In Community Settings

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

A Study LY2228820 for Recurrent Ovarian Cancer

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer